Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,102) with videos related to
Page
of 111
Sort By:
The Journal of Biological Chemistry
|
November 11, 2017
The nonproton ligand of acid-sensing ion channel 3 activates mollusk-specific FaNaC channels via a mechanism independent of the native FMRFamide peptide
Xiao-Na Yang, You-Ya Niu, Yan Liu, et al.
Expert Opinion on Investigational Drugs
|
February 9, 2023
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects
Yanli Wang, Jinling Xue, Zhengjie Su, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 12, 2022
A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects
Zhengzhi Liu, Zhenyue Gao, Wei Yang, et al.
Mutation Research
|
February 13, 2016
Genetic variants in multisynthetase complex genes are associated with DNA damage levels in Chinese populations
Jia Liu, Meng Zhu, Weihong Chen, et al.
Malaria Journal
|
May 24, 2017
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection
Yang Cheng, Bo Wang, Siriruk Changrob, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
Sandip P Patel, Teresa Alonso-Gordoa, Susana Banerjee, et al.
Gastroenterology
|
February 3, 2005
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection
Sébastien Dharancy, Mathilde Malapel, Gabriel Perlemuter, et al.
Cryobiology
|
March 19, 2023
Effects of sericin on oxidative stress and PI3K/AKT/mTOR signal pathway in cryopreserved mice ovarian tissue
Wei Han Shu, Song He Yang, Meng Wei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 20, 2025
VRK2 promotes colorectal cancer growth and impedes immunotherapy and 5-FU treatment efficacy
Yu-Tong Wu, Meng Gao, Kun-Yang Cheng, et al.
International Immunopharmacology
|
April 23, 2022
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects
Zhongnan Xu, Yanli Wang, Zhengzhi Liu, et al.
Page
of 111
Search research articles
Search
Showing results (1031-1040 of 1,102) with videos related to
Sort By:
Page
of 111
The Journal of Biological Chemistry
|
November 11, 2017
The nonproton ligand of acid-sensing ion channel 3 activates mollusk-specific FaNaC channels via a mechanism independent of the native FMRFamide peptide
Xiao-Na Yang, You-Ya Niu, Yan Liu, et al.
Expert Opinion on Investigational Drugs
|
February 9, 2023
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects
Yanli Wang, Jinling Xue, Zhengjie Su, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 12, 2022
A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects
Zhengzhi Liu, Zhenyue Gao, Wei Yang, et al.
Mutation Research
|
February 13, 2016
Genetic variants in multisynthetase complex genes are associated with DNA damage levels in Chinese populations
Jia Liu, Meng Zhu, Weihong Chen, et al.
Malaria Journal
|
May 24, 2017
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection
Yang Cheng, Bo Wang, Siriruk Changrob, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
Sandip P Patel, Teresa Alonso-Gordoa, Susana Banerjee, et al.
Gastroenterology
|
February 3, 2005
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection
Sébastien Dharancy, Mathilde Malapel, Gabriel Perlemuter, et al.
Cryobiology
|
March 19, 2023
Effects of sericin on oxidative stress and PI3K/AKT/mTOR signal pathway in cryopreserved mice ovarian tissue
Wei Han Shu, Song He Yang, Meng Wei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 20, 2025
VRK2 promotes colorectal cancer growth and impedes immunotherapy and 5-FU treatment efficacy
Yu-Tong Wu, Meng Gao, Kun-Yang Cheng, et al.
International Immunopharmacology
|
April 23, 2022
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects
Zhongnan Xu, Yanli Wang, Zhengzhi Liu, et al.
Page
of 111